speb/financial-data huggingface dataset:
NCH2.DE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -2000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 36000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 4000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Payables: 120000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Pretax Income: -1000000.00
NCH2.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 122000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Research And Development: 9000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 127000000.00
NCH2.DE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 5000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 18000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 126315000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 748000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 662000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 1000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 5000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 1132000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 748000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 29000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 748000000.00
NCH2.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 149000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 384000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 158000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 37000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 14000000.00
NCH2.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 626000000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 28300000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 50400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 81000000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 63500000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 506200000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 200000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 126000000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Basic EPS: -0.50
NCH2.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 676700000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5000000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -5000000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 28300000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 126300000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 683700000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 687100000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 0.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Change In Inventory: 14700000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 84800000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Change In Payable: -25300000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -7100000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 73800000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 6100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 126300000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 687400000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 87100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 974400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4600000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4600000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 413700000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 78100000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: -200000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 3500000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3500000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 126000000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.50
NCH2.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — EBIT: -61300000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — EBITDA: -57800000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 800000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 683700000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2400000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 8500000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 14100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 53100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 89300000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Gross Profit: -36700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 1800000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1800000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Interest Income: 3600000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3600000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 157100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 687400000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5000000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 200000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 23700000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 23700000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 200000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Income: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -63700000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -63700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: 1800000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1800000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1200000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 50800000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 598100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 16800000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 10200000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -57800000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Normalized Income: -63700000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 13500000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Operating Income: -65000000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 50400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 126315000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 35800000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 17000000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 36200000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3800000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 100000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 100000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 25900000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3400000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Payables: 88400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3700000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Pretax Income: -63100000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 87100000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3500000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Research And Development: 9600000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 63500000.00
NCH2.DE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 4600000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 18700000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 126315000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 687400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 598100000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 600000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 5000000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 1135300000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 687400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 28300000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 687400000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 115400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 447900000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 160900000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 34200000.00
NCH2.DE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -64800000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 7400000.00
NCH2.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 560700000.00
NCI balance_sheet (annual, 2021-12-31) — Accounts Payable: 84614300.00
NCI cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
NCI income_statement (annual, 2021-12-31) — Basic Average Shares: 508000.00
NCI income_statement (annual, 2021-12-31) — Basic EPS: 10.73
NCI cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -266559.00
NCI cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -589596.00
NCI cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: 0.00
NCI cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -266559.00
NCI balance_sheet (annual, 2021-12-31) — Current Deferred Assets: 583500.00
NCI income_statement (annual, 2021-12-31) — Diluted Average Shares: 508000.00
NCI income_statement (annual, 2021-12-31) — Diluted EPS: 10.73
NCI income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -5953.00
NCI cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 0.00
NCI income_statement (annual, 2021-12-31) — Insurance And Claims: 743218.00
NCI balance_sheet (annual, 2021-12-31) — Interest Payable: 381124.00
NCI balance_sheet (annual, 2021-12-31) — Long Term Debt: 525615.00
NCI balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 274686.00
NCI income_statement (annual, 2021-12-31) — Other Operating Expenses: -5217777.00
NCI income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
NCI income_statement (annual, 2021-12-31) — Total Unusual Items: -5953.00
NCI income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -5953.00
NCI income_statement (annual, 2021-12-31) — Write Off: 0.00
NCI income_statement (annual, 2022-12-31) — +Operating Expense: 22899648.00
NCI income_statement (annual, 2022-12-31) — +Total Revenue: 347451568.00
NCI balance_sheet (annual, 2022-12-31) — Accounts Payable: 10429941.00
NCI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 10339186.00
NCI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -502065.00
NCI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 91225.00
NCI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -31502.00
NCI income_statement (annual, 2022-12-31) — Amortization: 137358.00
NCI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 137358.00
NCI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 137358.00
NCI income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 137358.00
NCI income_statement (annual, 2022-12-31) — Basic Average Shares: 508000.00
NCI income_statement (annual, 2022-12-31) — Basic EPS: 24.41
NCI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1428243.00
NCI cash_flow (annual, 2022-12-31) — Capital Expenditure: -73526.00
NCI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 653344.00
NCI balance_sheet (annual, 2022-12-31) — Capital Stock: 8775.00
NCI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 8593063.00
NCI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 8593063.00
NCI cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
NCI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 49997884.00
NCI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -73526.00
NCI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -42759538.00
NCI cash_flow (annual, 2022-12-31) — Change In Account Payable: -74184359.00
NCI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 921015.00
NCI cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 3001914.00
NCI cash_flow (annual, 2022-12-31) — Change In Inventory: -619878.00
NCI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -3796835.00
NCI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
NCI cash_flow (annual, 2022-12-31) — Change In Payable: -71182445.00
NCI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -70261430.00
NCI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3796835.00
NCI cash_flow (annual, 2022-12-31) — Change In Receivables: 19369617.00
NCI cash_flow (annual, 2022-12-31) — Change In Tax Payable: 3001914.00
NCI cash_flow (annual, 2022-12-31) — Change In Working Capital: -55308526.00
NCI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 19369617.00
NCI cash_flow (annual, 2022-12-31) — Changes In Cash: 7164820.00
NCI balance_sheet (annual, 2022-12-31) — Common Stock: 8775.00
NCI cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
NCI balance_sheet (annual, 2022-12-31) — Common Stock Equity: -60675596.00
NCI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
NCI income_statement (annual, 2022-12-31) — Cost Of Revenue: 305616607.00
NCI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 412442.00
NCI balance_sheet (annual, 2022-12-31) — Current Assets: 40885741.00
NCI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 653344.00
NCI balance_sheet (annual, 2022-12-31) — Current Debt: 83962426.00
NCI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 84615770.00
NCI balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 4229639.00
NCI balance_sheet (annual, 2022-12-31) — Current Liabilities: 102173874.00
NCI cash_flow (annual, 2022-12-31) — Depreciation: 11114.00
NCI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 148472.00
NCI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 3342375.00
NCI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 148472.00
NCI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 3342375.00
NCI income_statement (annual, 2022-12-31) — Depreciation Income Statement: 3205017.00
NCI income_statement (annual, 2022-12-31) — Diluted Average Shares: 641000.00
NCI income_statement (annual, 2022-12-31) — Diluted EPS: 19.35
NCI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 12400516.00
NCI balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 16272733.00
NCI balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 0.00
NCI income_statement (annual, 2022-12-31) — EBIT: 21513889.00
NCI income_statement (annual, 2022-12-31) — EBITDA: 24856264.00
NCI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
NCI cash_flow (annual, 2022-12-31) — End Cash Position: 8593063.00
NCI cash_flow (annual, 2022-12-31) — Financing Cash Flow: 49997884.00
NCI balance_sheet (annual, 2022-12-31) — Finished Goods: 1299895.00
NCI cash_flow (annual, 2022-12-31) — Free Cash Flow: -42833064.00
NCI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -7444.00
NCI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1970738.00
NCI income_statement (annual, 2022-12-31) — General And Administrative Expense: 16926042.00
NCI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 112049.00
NCI balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 10370688.00
NCI balance_sheet (annual, 2022-12-31) — Gross PPE: 1210335.00
NCI income_statement (annual, 2022-12-31) — Gross Profit: 41834961.00
NCI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 21996.00
NCI income_statement (annual, 2022-12-31) — Insurance And Claims: 59595.00
NCI income_statement (annual, 2022-12-31) — Interest Expense: 6133455.00
NCI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 6133455.00
NCI income_statement (annual, 2022-12-31) — Interest Income: 1.00
NCI income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1.00
NCI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 6102137.00
NCI balance_sheet (annual, 2022-12-31) — Interest Payable: 412442.00
NCI balance_sheet (annual, 2022-12-31) — Inventory: 1299895.00
NCI balance_sheet (annual, 2022-12-31) — Invested Capital: 23661889.00
NCI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -73526.00
NCI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
NCI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 508716999.00
NCI balance_sheet (annual, 2022-12-31) — Leases: 0.00
NCI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
NCI balance_sheet (annual, 2022-12-31) — Long Term Debt: 375059.00
NCI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 375059.00
NCI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 508716999.00
NCI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -452377168.00
NCI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 556991.00
NCI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
NCI balance_sheet (annual, 2022-12-31) — Net Debt: 75744422.00
NCI income_statement (annual, 2022-12-31) — Net Income: 12400516.00
NCI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 12400516.00
NCI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 12400516.00
NCI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 12400516.00
NCI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 12400516.00
NCI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 12400516.00
NCI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 12400516.00
NCI cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
NCI income_statement (annual, 2022-12-31) — Net Interest Income: -6133454.00
NCI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 56339831.00
NCI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 56339831.00
NCI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -6133454.00
NCI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -6341947.00
NCI balance_sheet (annual, 2022-12-31) — Net PPE: 708270.00
NCI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -73526.00
NCI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -60787645.00
NCI balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 7876.00
NCI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 7876.00
NCI income_statement (annual, 2022-12-31) — Normalized EBITDA: 24856264.00
NCI income_statement (annual, 2022-12-31) — Normalized Income: 12400516.00
NCI cash_flow (annual, 2022-12-31) — Operating Cash Flow: -42759538.00
NCI income_statement (annual, 2022-12-31) — Operating Income: 18935313.00
NCI income_statement (annual, 2022-12-31) — Operating Revenue: 347451568.00
NCI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 508000.00
NCI balance_sheet (annual, 2022-12-31) — Other Current Assets: 21996.00
NCI balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 83962426.00
NCI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1970738.00
NCI income_statement (annual, 2022-12-31) — Other Gand A: 4489725.00
NCI income_statement (annual, 2022-12-31) — Other Income Expense: 2578575.00
NCI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 112049.00
NCI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 159401.00
NCI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2578575.00
NCI income_statement (annual, 2022-12-31) — Other Operating Expenses: -2586019.00
NCI balance_sheet (annual, 2022-12-31) — Other Payable: 924959.00
NCI balance_sheet (annual, 2022-12-31) — Other Properties: 653344.00
NCI balance_sheet (annual, 2022-12-31) — Payables: 17145662.00
NCI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 17558104.00
NCI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 129229.00
NCI income_statement (annual, 2022-12-31) — Pretax Income: 15380434.00
NCI balance_sheet (annual, 2022-12-31) — Properties: 0.00
NCI income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 0.00
NCI cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
NCI cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
NCI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -73526.00
NCI balance_sheet (annual, 2022-12-31) — Receivables: 26611919.00
NCI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 308810510.00
NCI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 148472.00
NCI income_statement (annual, 2022-12-31) — Rent And Landing Fees: 3205017.00
NCI income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 3205017.00
NCI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -452377168.00
NCI balance_sheet (annual, 2022-12-31) — Retained Earnings: -62746334.00
NCI income_statement (annual, 2022-12-31) — Salaries And Wages: 12436317.00
NCI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 2631231.00
NCI income_statement (annual, 2022-12-31) — Selling General And Administration: 19557273.00
NCI balance_sheet (annual, 2022-12-31) — Share Issued: 508000.00
NCI balance_sheet (annual, 2022-12-31) — Stockholders Equity: -60675596.00
NCI balance_sheet (annual, 2022-12-31) — Tangible Book Value: -60787645.00
NCI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
NCI income_statement (annual, 2022-12-31) — Tax Provision: 2979918.00
NCI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
NCI balance_sheet (annual, 2022-12-31) — Total Assets: 41873337.00
NCI balance_sheet (annual, 2022-12-31) — Total Capitalization: -60300537.00
NCI balance_sheet (annual, 2022-12-31) — Total Debt: 84990829.00
NCI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -60675596.00
NCI income_statement (annual, 2022-12-31) — Total Expenses: 328516255.00
NCI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 102548933.00
NCI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 987596.00
NCI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 375059.00
NCI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 18935313.00
NCI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 5790762.00
NCI income_statement (annual, 2022-12-31) — Total Unusual Items: -7444.00
NCI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -7444.00
NCI balance_sheet (annual, 2022-12-31) — Working Capital: -61288133.00
NCI income_statement (annual, 2023-12-31) — +Operating Expense: 26001786.00
NCI income_statement (annual, 2023-12-31) — +Total Revenue: 174202627.00
NCI balance_sheet (annual, 2023-12-31) — Accounts Payable: 0.00
NCI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 32343592.00
NCI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1474658.00
NCI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 55091225.00
NCI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1414818.00
NCI income_statement (annual, 2023-12-31) — Amortization: 112049.00
NCI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 112049.00
NCI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 112049.00
NCI income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 112049.00
NCI income_statement (annual, 2023-12-31) — Basic Average Shares: 508000.00
NCI income_statement (annual, 2023-12-31) — Basic EPS: 8.69
NCI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 8593063.00
NCI cash_flow (annual, 2023-12-31) — Capital Expenditure: -1275847.00
NCI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 23884854.00
NCI balance_sheet (annual, 2023-12-31) — Capital Stock: 8775.00
NCI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 5849306.00
NCI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 5849306.00
NCI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
NCI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 47546606.00
NCI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1275847.00
NCI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -49014516.00
NCI cash_flow (annual, 2023-12-31) — Change In Account Payable: -10429941.00
NCI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1173924.00
NCI cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -3969112.00
NCI cash_flow (annual, 2023-12-31) — Change In Inventory: -4088840.00
NCI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -14332426.00
NCI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3260273.00
NCI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 7876.00
NCI cash_flow (annual, 2023-12-31) — Change In Payable: -14399053.00
NCI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -13225129.00
NCI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -14332426.00
NCI cash_flow (annual, 2023-12-31) — Change In Receivables: -23387722.00
NCI cash_flow (annual, 2023-12-31) — Change In Tax Payable: -3969112.00
NCI cash_flow (annual, 2023-12-31) — Change In Working Capital: -55034117.00
NCI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -23387722.00
NCI cash_flow (annual, 2023-12-31) — Changes In Cash: -2743757.00
NCI balance_sheet (annual, 2023-12-31) — Common Stock: 8775.00
NCI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
NCI balance_sheet (annual, 2023-12-31) — Common Stock Equity: -2386810.00
NCI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
NCI income_statement (annual, 2023-12-31) — Cost Of Revenue: 139154316.00
NCI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 46397.00
NCI balance_sheet (annual, 2023-12-31) — Current Assets: 63738819.00
NCI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 708829.00
NCI balance_sheet (annual, 2023-12-31) — Current Debt: 30753400.00
NCI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 31462229.00
NCI balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 8148021.00
NCI balance_sheet (annual, 2023-12-31) — Current Liabilities: 69827614.00
NCI cash_flow (annual, 2023-12-31) — Deferred Income Tax: 7876.00
NCI cash_flow (annual, 2023-12-31) — Deferred Tax: 7876.00
NCI cash_flow (annual, 2023-12-31) — Depreciation: 33091.00
NCI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 145140.00
NCI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 145140.00
NCI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 145140.00
NCI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 145140.00
NCI income_statement (annual, 2023-12-31) — Depreciation Income Statement: 33091.00
NCI income_statement (annual, 2023-12-31) — Diluted Average Shares: 508000.00
NCI income_statement (annual, 2023-12-31) — Diluted EPS: 8.69
NCI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 4414733.00
NCI balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 0.00
NCI balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 34243244.00
NCI income_statement (annual, 2023-12-31) — EBIT: 11499052.00
NCI income_statement (annual, 2023-12-31) — EBITDA: 11644192.00
NCI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
NCI cash_flow (annual, 2023-12-31) — End Cash Position: 5849306.00
NCI cash_flow (annual, 2023-12-31) — Financing Cash Flow: 47546606.00
NCI balance_sheet (annual, 2023-12-31) — Finished Goods: 5320199.00
NCI cash_flow (annual, 2023-12-31) — Free Cash Flow: -50290363.00
NCI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -134428.00
NCI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 844791.00
NCI income_statement (annual, 2023-12-31) — General And Administrative Expense: 21341053.00
NCI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
NCI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 33758410.00
NCI balance_sheet (annual, 2023-12-31) — Gross PPE: 26657194.00
NCI income_statement (annual, 2023-12-31) — Gross Profit: 35048311.00
NCI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 3314625.00
NCI income_statement (annual, 2023-12-31) — Interest Expense: 5759182.00
NCI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 5759182.00
NCI income_statement (annual, 2023-12-31) — Interest Income: 92951.00
NCI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 92951.00
NCI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 6134748.00
NCI balance_sheet (annual, 2023-12-31) — Interest Payable: 46397.00
NCI balance_sheet (annual, 2023-12-31) — Inventory: 5320199.00
NCI balance_sheet (annual, 2023-12-31) — Invested Capital: 28366590.00
NCI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1275847.00
NCI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
NCI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 115018274.00
NCI balance_sheet (annual, 2023-12-31) — Leases: 2169258.00
NCI balance_sheet (annual, 2023-12-31) — Line Of Credit: 30753400.00
NCI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 23176025.00
NCI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 23176025.00
NCI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 115018274.00
NCI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -168602359.00
NCI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 603082.00
NCI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
NCI balance_sheet (annual, 2023-12-31) — Net Debt: 24904094.00
NCI income_statement (annual, 2023-12-31) — Net Income: 4414733.00
NCI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 4414733.00
NCI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 4414733.00
NCI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4414733.00
NCI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 4414733.00
NCI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4414733.00
NCI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4414733.00
NCI cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
NCI income_statement (annual, 2023-12-31) — Net Interest Income: -5666231.00
NCI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -53584085.00
NCI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -53584085.00
NCI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -5666231.00
NCI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 101130691.00
NCI balance_sheet (annual, 2023-12-31) — Net PPE: 25182536.00
NCI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1275847.00
NCI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -2386810.00
NCI balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
NCI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
NCI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
NCI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
NCI income_statement (annual, 2023-12-31) — Normalized EBITDA: 11778620.00
NCI income_statement (annual, 2023-12-31) — Normalized Income: 4518108.13
NCI cash_flow (annual, 2023-12-31) — Operating Cash Flow: -49014516.00
NCI income_statement (annual, 2023-12-31) — Operating Income: 9046525.00
NCI income_statement (annual, 2023-12-31) — Operating Revenue: 174202627.00
NCI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 508000.00
NCI balance_sheet (annual, 2023-12-31) — Other Current Assets: 55863.00
NCI balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 30753400.00
NCI balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 844791.00
NCI income_statement (annual, 2023-12-31) — Other Gand A: 4852973.00
NCI income_statement (annual, 2023-12-31) — Other Income Expense: 2359576.00
NCI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1695474.00
NCI income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2494004.00
NCI income_statement (annual, 2023-12-31) — Other Operating Expenses: -2662360.00
NCI balance_sheet (annual, 2023-12-31) — Other Payable: 2324406.00
NCI balance_sheet (annual, 2023-12-31) — Other Properties: 23884854.00
NCI balance_sheet (annual, 2023-12-31) — Payables: 38318988.00
NCI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 38365385.00
NCI balance_sheet (annual, 2023-12-31) — Prepaid Assets: 12021838.00
NCI income_statement (annual, 2023-12-31) — Pretax Income: 5739870.00
NCI balance_sheet (annual, 2023-12-31) — Properties: 0.00
NCI income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 1383316.00
NCI cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1451852.00
NCI cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
NCI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1275847.00
NCI balance_sheet (annual, 2023-12-31) — Receivables: 32343592.00
NCI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 139154316.00
NCI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 145140.00
NCI income_statement (annual, 2023-12-31) — Rent And Landing Fees: 3227182.00
NCI income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 3227182.00
NCI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -168602359.00
NCI balance_sheet (annual, 2023-12-31) — Retained Earnings: -58331601.00
NCI income_statement (annual, 2023-12-31) — Salaries And Wages: 13260898.00
NCI income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 3132277.00
NCI income_statement (annual, 2023-12-31) — Selling General And Administration: 24473330.00
NCI balance_sheet (annual, 2023-12-31) — Share Issued: 508000.00
NCI balance_sheet (annual, 2023-12-31) — Stockholders Equity: -2386810.00
NCI balance_sheet (annual, 2023-12-31) — Tangible Book Value: -2386810.00
NCI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -31052.87
NCI income_statement (annual, 2023-12-31) — Tax Provision: 1325137.00
NCI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
NCI balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
NCI balance_sheet (annual, 2023-12-31) — Total Assets: 90616829.00
NCI balance_sheet (annual, 2023-12-31) — Total Capitalization: -2386810.00
NCI balance_sheet (annual, 2023-12-31) — Total Debt: 54638254.00
NCI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -2386810.00
NCI income_statement (annual, 2023-12-31) — Total Expenses: 165156102.00
NCI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 93003639.00
NCI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 26878010.00
NCI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 23176025.00
NCI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 9046525.00
NCI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1751338.00
NCI income_statement (annual, 2023-12-31) — Total Unusual Items: -134428.00
NCI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -134428.00
NCI balance_sheet (annual, 2023-12-31) — Working Capital: -6088795.00
NCI income_statement (annual, 2024-12-31) — +Operating Expense: 37873129.00
NCI income_statement (annual, 2024-12-31) — +Total Revenue: 235667734.00
NCI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 34169661.00
NCI balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 34169661.00
NCI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2111354.00
NCI balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2111354.00
NCI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 106085870.00
NCI balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 106085870.00
NCI balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2668186.00
NCI balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2668186.00
NCI income_statement (annual, 2024-12-31) — Amortization: 1481738.00
NCI cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 1481738.00
NCI cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 1481738.00
NCI income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 1481738.00
NCI income_statement (annual, 2024-12-31) — Basic Average Shares: 490092.00
NCI income_statement (annual, 2024-12-31) — Basic EPS: 16.48
NCI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 5849306.00
NCI cash_flow (annual, 2024-12-31) — Capital Expenditure: -19167148.00
NCI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 42491805.00
NCI balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 42491805.00
NCI balance_sheet (annual, 2024-12-31) — Capital Stock: 9906.00
NCI balance_sheet (quarterly, 2024-12-31) — Capital Stock: 9906.00
NCI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 9166020.00
NCI balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 9166020.00
NCI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 9166020.00
NCI balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 9166020.00
NCI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 21891118.00
NCI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -19167148.00
NCI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 428243.00
NCI cash_flow (annual, 2024-12-31) — Change In Account Payable: 0.00
NCI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 4087119.00
NCI cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -543951.00
NCI cash_flow (annual, 2024-12-31) — Change In Inventory: 1679793.00
NCI cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 713336.00
NCI cash_flow (annual, 2024-12-31) — Change In Payable: -543951.00
NCI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3543168.00
NCI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -12940934.00
NCI cash_flow (annual, 2024-12-31) — Change In Receivables: -4074387.00
NCI cash_flow (annual, 2024-12-31) — Change In Tax Payable: -543951.00
NCI cash_flow (annual, 2024-12-31) — Change In Working Capital: -11792360.00
NCI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -3079437.00
NCI cash_flow (annual, 2024-12-31) — Changes In Cash: 3152213.00
NCI balance_sheet (annual, 2024-12-31) — Common Stock: 9906.00
NCI balance_sheet (quarterly, 2024-12-31) — Common Stock: 9906.00
NCI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 56826471.00
NCI balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 56826471.00
NCI cash_flow (annual, 2024-12-31) — Common Stock Issuance: 65641784.00
NCI income_statement (annual, 2024-12-31) — Cost Of Revenue: 186223181.00
NCI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1087478.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 1087478.00
NCI balance_sheet (annual, 2024-12-31) — Current Assets: 72335182.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Assets: 72335182.00
NCI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 3890482.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 3890482.00
NCI balance_sheet (annual, 2024-12-31) — Current Debt: 27105722.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Debt: 27105722.00
NCI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 30996204.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 30996204.00
NCI balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 0.00
NCI balance_sheet (annual, 2024-12-31) — Current Liabilities: 39299756.00
NCI balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 39299756.00
NCI cash_flow (annual, 2024-12-31) — Deferred Income Tax: 713336.00
NCI cash_flow (annual, 2024-12-31) — Deferred Tax: 713336.00
NCI cash_flow (annual, 2024-12-31) — Depreciation: 685245.00
NCI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2166983.00
NCI income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 2166983.00
NCI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2166983.00
NCI income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 2166983.00
NCI income_statement (annual, 2024-12-31) — Depreciation Income Statement: 685245.00
NCI income_statement (annual, 2024-12-31) — Diluted Average Shares: 490092.00
NCI income_statement (annual, 2024-12-31) — Diluted EPS: 16.48
NCI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 8063331.00
NCI balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 0.00
NCI balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 638243.00
NCI balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 638243.00
NCI income_statement (annual, 2024-12-31) — EBIT: 12908272.00
NCI income_statement (annual, 2024-12-31) — EBITDA: 15075255.00
NCI cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 164501.00
NCI cash_flow (annual, 2024-12-31) — End Cash Position: 9166020.00
NCI cash_flow (annual, 2024-12-31) — Financing Cash Flow: 21891118.00
NCI balance_sheet (annual, 2024-12-31) — Finished Goods: 3616821.00
NCI balance_sheet (quarterly, 2024-12-31) — Finished Goods: 3616821.00
NCI cash_flow (annual, 2024-12-31) — Free Cash Flow: -18738905.00
NCI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 998965.00
NCI balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 998965.00
NCI income_statement (annual, 2024-12-31) — General And Administrative Expense: 30060257.00
NCI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 13541442.00
NCI balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 13541442.00
NCI balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 36837847.00
NCI balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 36837847.00
NCI balance_sheet (annual, 2024-12-31) — Gross PPE: 49349237.00
NCI balance_sheet (quarterly, 2024-12-31) — Gross PPE: 49349237.00
NCI income_statement (annual, 2024-12-31) — Gross Profit: 49444553.00
NCI cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1887737.00
NCI income_statement (annual, 2024-12-31) — Interest Expense: 3759032.00
NCI income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3759032.00
NCI income_statement (annual, 2024-12-31) — Interest Income: 31954.00
NCI income_statement (annual, 2024-12-31) — Interest Income Non Operating: 31954.00
NCI cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 3314316.00
NCI balance_sheet (annual, 2024-12-31) — Interest Payable: 0.00
NCI balance_sheet (quarterly, 2024-12-31) — Interest Payable: 0.00
NCI balance_sheet (annual, 2024-12-31) — Inventory: 3616821.00
NCI balance_sheet (quarterly, 2024-12-31) — Inventory: 3616821.00
NCI balance_sheet (annual, 2024-12-31) — Invested Capital: 83932193.00